Chromatide Wins $145K Grant to Develop Enzyme-Immobiliziation Tech | GenomeWeb
NEW YORK (GenomeWeb News) — Purification products maker Chromatide said today it has won a £70,000 ($145,000) NorthWest Regional Development Agency award to develop enzyme-immobilization technology.
The Cheshire, UK-based company said the technology will lower the cost of immobilizing enzymes, which could simplify drug-development and chemical-production processes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.